Cargando…

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

Lung transplant (LuTx) recipients are considered to be at higher risk of developing serious illness from COVID-19. COVID-19 vaccines were shown in randomized clinical trials to substantially reduce the severity of COVID-19, however, patients receiving immunosuppressants were excluded from these tria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svorcova, Monika, Novysedlak, Rene, Lischke, Robert, Vachtenheim, Jiri, Strizova, Zuzana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198330/ https://www.ncbi.nlm.nih.gov/pubmed/35720376 http://dx.doi.org/10.3389/fimmu.2022.906225

Ejemplares similares

How COVID-19 Affects Lung Transplantation: A Comprehensive Review
por: Vachtenheim, Jiri, et al.
Publicado: (2022)

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report
por: Vachtenheim, Jiri, et al.
Publicado: (2020)

Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
por: Havlin, Jan, et al.
Publicado: (2021)

Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
por: Ozaniak, Andrej, et al.
Publicado: (2021)

Rare Pseudosarcomatous Lesions Posing Diagnostic Challenges: Histopathologic Examination as a Dominant Tool Preventing Misdiagnosis of Proliferative Fasciitis
por: Ozaniak, Andrej, et al.
Publicado: (2022)

Tumoral and paratumoral NK cells and CD8(+) T cells of esophageal carcinoma patients express high levels of CD47
por: Strizova, Zuzana, et al.
Publicado: (2020)

M1/M2 macrophages and their overlaps – myth or reality?
por: Strizova, Zuzana, et al.
Publicado: (2023)

Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients
por: Chen, Chien-Chia, et al.
Publicado: (2022)

The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials
por: Snajdauf, Martin, et al.
Publicado: (2021)

Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
por: Luo, Xinyi, et al.
Publicado: (2023)

Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene
por: Vachtenheim, Jiri, et al.
Publicado: (2018)

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines
por: Duan, Binwei, et al.
Publicado: (2022)

Esophageal bypass surgery as a definitive repair of recurrent acquired benign bronchoesophageal fistula
por: Vachtenheim, Jiri, et al.
Publicado: (2019)

CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
por: Taborska, Pavla, et al.
Publicado: (2021)

Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial
por: Vajter, Jaromir, et al.
Publicado: (2023)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination-Induced Immunogenicity in Heart Transplant Recipients
por: Memenga, Felix, et al.
Publicado: (2023)

Diagnostic challenges and treatment options in patients with solitary fibrous tumor: A single-center observational study
por: Ozaniak, Andrej, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses
por: Grupper, Ayelet, et al.
Publicado: (2022)

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
por: Han, Yuling, et al.
Publicado: (2022)

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)

Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients
por: Furian, Lucrezia, et al.
Publicado: (2022)

Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity
por: Duquesnoy, René J.
Publicado: (2011)

Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients
por: Gaete-Argel, Aracelly, et al.
Publicado: (2023)

Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines
por: al Jalali, Valentin, et al.
Publicado: (2021)

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate
por: Perdiguero, Beatriz, et al.
Publicado: (2023)

Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022)

Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients
por: Hirama, Takashi, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022)

Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021)

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients
por: Takai, Satoshi, et al.
Publicado: (2022)

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Zitt, Emanuel, et al.
Publicado: (2021)

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study
por: Tao, Jun, et al.
Publicado: (2021)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
por: Al Jurdi, Ayman, et al.
Publicado: (2022)

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
por: Kimura, Muneyoshi, et al.
Publicado: (2022)

Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer
por: Song, Rui, et al.
Publicado: (2022)

Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2
por: Devresse, Arnaud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31debkeg7bdh765nvkpi2hb0hd